NEW YORK, March 11 (GeneWeb News) - Cheminformatics provider Sertanty and structural informatics company Eidogen -- both privately held firms -- said earlier this week that they have merged to become Eidogen-Sertanty.

Steven Muskal, founder and CEO of Sertanty, is CEO of the new company, and Derek Debe, founder and CEO of Eidogen, has assumed the role of CSO.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.